InflaRx (IFRX) Return on Assets (2017 - 2026)
InflaRx's (IFRX) quarterly Return on Assets came in at 353.57% in Q1 2026, up 35357.0% year-on-year from N/an in Q1 2025, and up 15.58% quarter-over-quarter from 305.91% in Q4 2025.
InflaRx (IFRX) Return on Assets (2017 - 2026) Analysis & Trends
InflaRx has disclosed Return on Assets across 10 years of filings, most recently posting 353.57% for Q1 2026.
- Return on Assets for Q1 2026 came in at 353.57%, up 35357.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 353.57% (up 35357.0% YoY), and the FY2025 annual result was 0.01%, changed 0.0% from the prior year.
- Return on Assets came in at 353.57% for Q1 2026 at InflaRx, up from 305.91% in the prior quarter.
- In the past five years, Return on Assets ranged from a high of 353.57% in Q1 2026 to a low of 0.01% in Q3 2024.
- The 5-year median for Return on Assets is 12.2% (2022), against an average of 55.0%.
- Across the five-year window, Return on Assets plunged 223855 bps in 2022 and soared 35357 bps in 2026, its largest moves.
- InflaRx's Return on Assets stood at 19.24% in 2022, then surged by 91 bps to 36.66% in 2023, then sank by 100 bps to 0.0% in 2024, then surged by 53521545 bps to 305.91% in 2025, then gained by 16 bps to 353.57% in 2026.
- The last three Return on Assets figures came in at 353.57% (Q1 2026), 305.91% (Q4 2025), and 0.0% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | -0.80% |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | -0.01% |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | 0.00% |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | -0.01% |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | 0.00% |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | 0.00% |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 0.00% |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | -0.01% |
| 10 | InflaRx | 764.68 Mn | 764.68 Mn | 10,877.40 | 353.57% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 353.57% |
| Dec 31, 2025 | 305.91% |
| Sep 30, 2025 | 0.00% |
| Jun 30, 2025 | 0.00% |
| Mar 31, 2025 | 0.00% |
| Dec 31, 2024 | 0.00% |
| Sep 30, 2024 | -0.01% |
| Jun 30, 2024 | 0.00% |
| Mar 31, 2024 | 0.00% |
| Dec 31, 2023 | 36.66% |
| Sep 30, 2023 | 34.67% |
| Jun 30, 2023 | 59.28% |
| Mar 31, 2023 | 71.40% |
| Dec 31, 2022 | 19.24% |
| Sep 30, 2022 | 30.87% |
| Jun 30, 2022 | 12.20% |
| Mar 31, 2022 | 11.27% |
| Dec 31, 2021 | 10.38% |
| Sep 30, 2021 | 2,018.70% |
| Jun 30, 2021 | 1,870.06% |